{"disease":{"id":"light-headedness","name":"light headedness"},"drugs":{"marketed":[{"drug_id":"droxidopa","indication_name":"Orthostatic dizziness, lightheadedness, or the feeling of about to black out due to nOH","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Northera","generic_name":"DROXIDOPA","company_name":"Lundbeck Na Ltd","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1","drug_class":"Catecholamine","quality_score":10,"revenue":null,"mechanism":"Northera works by increasing the levels of certain neurotransmitters in the brain, such as norepinephrine, to help regulate blood pressure and movement."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05821465","title":"Ambulatory Leadless Electrocardiogram Recorder Trial Feasibility","phase":"","overall_status":"COMPLETED","enrollment_count":144,"lead_sponsor_name":"HelpWear Inc.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}